Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9APC9
Term | Name | Level | Count |
---|---|---|---|
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016310 | phosphorylation | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016301 | kinase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 135 | 139 | PF00656 | 0.418 |
CLV_C14_Caspase3-7 | 3 | 7 | PF00656 | 0.617 |
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.501 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.407 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.443 |
CLV_PCSK_SKI1_1 | 193 | 197 | PF00082 | 0.229 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.282 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.138 |
DEG_APCC_DBOX_1 | 52 | 60 | PF00400 | 0.531 |
DEG_SPOP_SBC_1 | 86 | 90 | PF00917 | 0.488 |
DOC_CKS1_1 | 25 | 30 | PF01111 | 0.371 |
DOC_CYCLIN_RxL_1 | 144 | 156 | PF00134 | 0.525 |
DOC_CYCLIN_RxL_1 | 18 | 27 | PF00134 | 0.411 |
DOC_CYCLIN_yCln2_LP_2 | 71 | 77 | PF00134 | 0.482 |
DOC_MAPK_gen_1 | 163 | 170 | PF00069 | 0.398 |
DOC_MAPK_MEF2A_6 | 163 | 170 | PF00069 | 0.357 |
DOC_PP2B_LxvP_1 | 75 | 78 | PF13499 | 0.668 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.455 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.585 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.516 |
DOC_WW_Pin1_4 | 229 | 234 | PF00397 | 0.576 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.433 |
LIG_14-3-3_CanoR_1 | 87 | 93 | PF00244 | 0.456 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.673 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.673 |
LIG_BRCT_BRCA1_1 | 88 | 92 | PF00533 | 0.612 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.476 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.609 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.654 |
LIG_LIR_Gen_1 | 106 | 113 | PF02991 | 0.348 |
LIG_LIR_Gen_1 | 46 | 56 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 106 | 111 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 35 | 39 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.266 |
LIG_SH2_PTP2 | 108 | 111 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.250 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.408 |
LIG_SH3_1 | 205 | 211 | PF00018 | 0.424 |
LIG_SH3_2 | 208 | 213 | PF14604 | 0.424 |
LIG_SH3_3 | 205 | 211 | PF00018 | 0.453 |
LIG_SH3_3 | 71 | 77 | PF00018 | 0.604 |
LIG_SUMO_SIM_anti_2 | 165 | 170 | PF11976 | 0.461 |
LIG_SUMO_SIM_par_1 | 22 | 27 | PF11976 | 0.400 |
LIG_TYR_ITSM | 104 | 111 | PF00017 | 0.413 |
LIG_WRC_WIRS_1 | 121 | 126 | PF05994 | 0.402 |
MOD_CK1_1 | 181 | 187 | PF00069 | 0.556 |
MOD_CK2_1 | 120 | 126 | PF00069 | 0.289 |
MOD_Cter_Amidation | 147 | 150 | PF01082 | 0.465 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.550 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.618 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.494 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.497 |
MOD_N-GLC_1 | 221 | 226 | PF02516 | 0.421 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.428 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.427 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.402 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.498 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.475 |
MOD_PIKK_1 | 124 | 130 | PF00454 | 0.477 |
MOD_PIKK_1 | 221 | 227 | PF00454 | 0.600 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.383 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.412 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.520 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.433 |
TRG_DiLeu_BaEn_1 | 54 | 59 | PF01217 | 0.458 |
TRG_DiLeu_BaEn_4 | 54 | 60 | PF01217 | 0.411 |
TRG_DiLeu_BaLyEn_6 | 215 | 220 | PF01217 | 0.344 |
TRG_DiLeu_LyEn_5 | 54 | 59 | PF01217 | 0.458 |
TRG_ENDOCYTIC_2 | 108 | 111 | PF00928 | 0.250 |
TRG_Pf-PMV_PEXEL_1 | 172 | 176 | PF00026 | 0.403 |
TRG_Pf-PMV_PEXEL_1 | 57 | 62 | PF00026 | 0.360 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P894 | Leptomonas seymouri | 62% | 95% |
A0A0S4JTH8 | Bodo saltans | 35% | 100% |
A0A1X0NPH5 | Trypanosomatidae | 36% | 80% |
A0A3S7WSM5 | Leishmania donovani | 91% | 98% |
A0A422NGD0 | Trypanosoma rangeli | 39% | 90% |
A4H793 | Leishmania braziliensis | 79% | 100% |
A4HVN3 | Leishmania infantum | 91% | 98% |
D0A6L3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 89% |
P56597 | Homo sapiens | 24% | 100% |
Q4QG49 | Leishmania major | 89% | 100% |
V5DBS4 | Trypanosoma cruzi | 40% | 90% |